MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0019358
Maxheal Pharmaceuticals (India) Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹82.41 Cr
▲ 10% YoY
Net profit · FY 2024
₹44.48 Lakh
Net margin 0.5%
EBITDA · FY 2024
₹4.53 Cr
EBITDA margin 5.5%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹33.68 Cr
Satisfied ₹91.87 Cr
Company age
17 yrs
Est. 2009
Employees · EPFO
67
Provident fund records
About Maxheal Pharmaceuticals (India) Limited
Data last updated:
Maxheal Pharmaceuticals (India) Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 June 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U73100MH2009PLC193624. Its GSTIN is 27AAGCM0717K1ZF (Maharashtra). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹1 Cr. It was formerly known as Maxheal Pharmaceuticals Limited. It is led by directors including Mehul Madan Sakhala (Managing Director) and Pranita Mehul Sakhala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹82.41 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹44.48 Lakh (net margin 0.5%) and EBITDA of ₹4.53 Cr (EBITDA margin 5.5%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 1% over five years.
The company has about 67 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹33.68 Cr and satisfied charges of ₹91.87 Cr on record. Court records list 13 cases involving the company, including 6 filed by the company and 7 filed against it; 2 cases are pending.
Maxheal Pharmaceuticals (India) Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0019358). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maxheal.in.
Company details
CIN U73100MH2009PLC193624
Registration Number 193624
Incorporation Date 29 June 2009
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0019358
Key People
Mehul Madan Sakhala Managing Director Pranita Mehul Sakhala Director Hemlata Madanlal Sakhala Director Recognitions & Rankings of Maxheal Pharmaceuticals (India)
Contact details
Maxheal Pharmaceuticals (India) Limited's registered office is in Mumbai, Maharashtra. Its website is maxheal.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address301 3rd Floor Maxheal House Plot No. Cst No. 1043 Bangur Nagar Goregaon (We, St), Mumbai, Maharashtra, India – 400090
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maxheal Pharmaceuticals (India) Limited, buy the company report.
Comprehensive company report
Maxheal Pharmaceuticals (India) Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Maxheal Pharmaceuticals (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Maxheal Pharmaceuticals (India) Limited, buy the company report.
Financials of Maxheal Pharmaceuticals (India) Limited
FY 2025 filings availableMaxheal Pharmaceuticals (India) Limited reported revenue of ₹82.41 Cr (up 10% YoY) for FY 2024.
Revenue · FY 2024
₹82.41 Cr ▲ 10%
Net profit · FY 2024
₹44.48 Lakh margin 0.5%
EBITDA · FY 2024
₹4.53 Cr margin 5.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▼ 3%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 3%
5 years · compounded
▼ 9%
Revenue rose 10% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹82.41 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.53 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹44.48 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maxheal Pharmaceuticals (India) Limited, buy the company report.
Board of directors of Maxheal Pharmaceuticals (India) Limited
Maxheal Pharmaceuticals (India) has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pranita Mehul Sakhala | Director | 01 Jul 2017 | 9 Years 4 Months | Current |
| Hemlata Madanlal Sakhala Also directs: Maxheal Laboratories Private Limited | Director | 29 Jun 2009 | 17 Years 4 Months | Current |
| Madanlal Mohanlal Sakhala Also directs: Maxheal Laboratories Private Limited | Director | 01 Jul 2012 | 14 Years 4 Months | Current |
| Mehul Madan Sakhala Also directs: Maxheal Laboratories Private Limited | Managing Director | 29 Jun 2009 | 17 Years 4 Months | Current |
Peer comparison
Maxheal Pharmaceuticals (India) Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brooks Laboratories Limited | ₹83.44 Cr (FY 2025) | 4.0% | Nalagarh, Himachal Pradesh, India | |||
| J Duncan Healthcare Private Limited | ₹82.47 Cr (FY 2025) | -57.0% | Shahapur, Maharashtra, India | |||
| Abhilash Chemicals and Pharmaceuticals Private Limited | ₹82.45 Cr (FY 2025) | -16.0% | Madurai, Tamil Nadu, India | |||
| Maxheal Pharmaceuticals (India) Limitedthis company | ₹82.41 Cr (FY 2024) | ₹44.48 Lakh | 0.5% | 10.0% | 67 | Mumbai, Maharashtra, India |
| Mepromax Life Sciences Private Limited | ₹82.29 Cr (FY 2025) | 2.0% | Wadhwan, Gujarat, India | |||
| Himalaya Meditek Private Limited | ₹82.23 Cr (FY 2024) | 3.0% | Hyderabad, Telangana, India | |||
| Beacon Diagnostics Pvt Ltd | ₹82.21 Cr (FY 2025) | -1.0% | Navsari, Gujarat, India | |||
| Supreem Pharmaceuticals Mysore Private Limited | ₹82.17 Cr (FY 2025) | 21.0% | Nanjangudu, Karnataka, India | |||
| JFL Life Sciences Limited | ₹82.05 Cr (FY 2025) | 74.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Maxheal Pharmaceuticals (India) Limited, buy the company report.
Auditor
Maxheal Pharmaceuticals (India) Limited is audited by S.B.Chhajed & Co for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.B.Chhajed & Co | FY 2024 | 101802W |
Shareholding
The shareholding of Maxheal Pharmaceuticals (India) Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maxheal Pharmaceuticals (India) Limited, buy the company report.
Charges & borrowings
Open charges
₹33.68 Cr
Satisfied charges
₹91.87 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Jul 2010 | 10232163 | State Bank of India | ₹33.68 Cr | Open | |
| 18 Jan 2021 | 100409547 | Others | ₹2.56 Cr | Satisfied | |
| 26 May 2020 | 100338834 | Others | ₹1.2 Cr | Satisfied | |
| 02 May 2018 | 100175524 | State Bank of India | ₹10.05 Cr | Satisfied | |
| 20 May 2017 | 100100956 | Others | ₹4.47 Cr | Satisfied |
To see the full charge records of Maxheal Pharmaceuticals (India) Limited, buy the company report.
Total charge records: 10 View all charges
Legal cases
Maxheal Pharmaceuticals (India) Limited has 13 court cases on record: 6 filed by Maxheal Pharmaceuticals (India), 7 filed against it. 2 cases are pending and 11 are disposed.
Total cases
13
Filed by the company
6
Filed against the company
7
Pending
2
Disposed
11
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 7 | 2 |
| High courts | 4 | 0 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Court case (CARAP) | Filed by the company against Kopran Research Laboratories Limited | Disposed |
| Bombay High Court | Court case (CARBP) | Filed by the company against Kopran Research Laboratories Limited | Disposed |
| District court, Thane, Maharashtra | Civil suit | Filed against the company | Pending |
| District court, Nashik, Maharashtra | Civil suit | Filed against the company by Union of India THR Swapnil Patil , Drugs Inpector , Office of the Deputy Drugs Contro | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Notice cases) | Filed by the company against an individual | Disposed |
To see the full case history of Maxheal Pharmaceuticals (India) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Maxheal Pharmaceuticals (India) Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 638 overdue payments to 45 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 45)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| A.R Packaging | |||
| an individual supplier | |||
| an individual supplier | |||
| Belding India Limited | |||
| Printmann Offset Private Limited CN |
To see the full MSME payment records of Maxheal Pharmaceuticals (India) Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Maxheal Pharmaceuticals (India) Limited has a workforce of 67 employees on its EPFO records as of Feb 27, 2025, across 3 active EPFO establishments.
Employee count
67
Active EPFO establishments
3
Employee growth
-50.74%
GST
Maxheal Pharmaceuticals (India) has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCM0717K1ZF | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Maxheal Pharmaceuticals (India) Limited, buy the company report.
Recent activity
Maxheal Pharmaceuticals (India) Limited has 6 board changes on record since 2009: 4 appointments and 2 cessations. The latest: Mehul Madan Sakhala ceased to be Director on 01 Jul 2017.
AGM
Maxheal Pharmaceuticals (India) Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Maxheal Pharmaceuticals (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 02 May 2018 via Charge ID 100175524 with State Bank Of India was fully satisfied on 20 May 2023.
Charges
A charge with State Bank Of India of Rs. 33.68 Cr registered on 13 Jul 2010 with Charge ID 10232163 was modified on 20 Feb 2023.
Charges
A charge registered on 02 Sep 2011 via Charge ID 10306801 with Others was fully satisfied on 24 Mar 2022.
Charges
A charge registered on 18 Jan 2021 via Charge ID 100409547 with Others was fully satisfied on 16 Oct 2021.
Charges
A charge registered on 26 May 2020 via Charge ID 100338834 with Others was fully satisfied on 16 Oct 2021.
Charges
A charge registered on 08 Apr 2010 via Charge ID 10213957 with Others was fully satisfied on 16 Oct 2021.
Charges
A charge registered on 20 May 2017 via Charge ID 100100956 with Others was fully satisfied on 02 Feb 2021.
Charges
A charge with Others amounted to Rs. 2.56 Cr with Charge ID 100409547 was registered on 18 Jan 2021.
Charges
A charge with Others amounted to Rs. 1.20 Cr with Charge ID 100338834 was registered on 26 May 2020.
Charges
A charge with Others of Rs. 23.82 Cr registered on 02 Sep 2011 with Charge ID 10306801 was modified on 02 Aug 2018.
22 earlier events are in the company report.
Frequently asked questions
Maxheal Pharmaceuticals (India) is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 June 2009 (17+ years old) and is registered under CIN U73100MH2009PLC193624.
Maxheal Pharmaceuticals (India) has 4 current directors:
- Mehul Madan Sakhala - Managing Director
- Pranita Mehul Sakhala - Director
- Hemlata Madanlal Sakhala - Director
- Madanlal Mohanlal Sakhala - Director
The latest financial statements of Maxheal Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Maxheal Pharmaceuticals (India) is 27AAGCM0717K1ZF, registered in Maharashtra. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Maxheal Pharmaceuticals (India) is U73100MH2009PLC193624. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxheal Pharmaceuticals (India) has 13 court cases on record: 6 filed by the company and 7 filed against it. 2 are pending. Most are in the district courts.
Maxheal Pharmaceuticals (India) was incorporated on 29 June 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Maxheal Pharmaceuticals (India) by revenue are Brooks Laboratories Limited, J Duncan Healthcare Private Limited, Abhilash Chemicals and Pharmaceuticals Private Limited, Mepromax Life Sciences Private Limited, Himalaya Meditek Private Limited and 3 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mehul Madan Sakhala ceased to be Director on 01 Jul 2017. Pranita Mehul Sakhala was appointed as Director on 01 Jul 2017. Madanlal Mohanlal Sakhala ceased to be Managing Director on 30 Jun 2017. Maxheal Pharmaceuticals (India) has 6 board changes on record in total.
Yes, Maxheal Pharmaceuticals (India) is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0019358).
Maxheal Pharmaceuticals (India) has 14 MSME Form 1 returns on record between 2019 and 2024, listing 638 overdue payments to 45 micro and small suppliers. The latest return was filed on 29 Apr 2024.
Maxheal Pharmaceuticals (India) can be reached through the website maxheal.in. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages